|
|
- 2018
Setbacks in Alzheimer research demand new strategies, not surrenderDOI: 10.1371/journal.pmed.1002518 Keywords: Alzheimer's disease,Dementia,Drug research and development,Cognitive impairment,Cognitive neurology,Drug therapy,Health economics,Socioeconomic aspects of health Abstract: In this month’s editorial, the PLOS Medicine Editors discuss the challenges of addressing a growing population with Alzheimer disease and dementia amidst disappointing news from the pharmaceutical industry
|
